Charles York
Directeur Financier/CFO chez DAY ONE BIOPHARMACEUTICALS, INC.
Fortune : 3 M $ au 30/04/2024
Profil
Charles N.
York is currently the Chief Operating & Financial Officer at DOT Therapeutics-2, Inc. and the Chief Operating & Financial Officer, Secretary at Day One Biopharmaceuticals, Inc. Previously, he worked as the Controller at Astrotech Corp.
from 2009 to 2012 and as the Chief Financial Officer, Secretary & VP at Spyre Therapeutics, Inc. from 2014 to 2021.
Mr. York obtained his undergraduate degree from the University of Connecticut in 1999 and his MBA from the McCombs School of Business in 2006.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/05/2024 | 224 868 ( 0,26% ) | 3 M $ | 30/04/2024 |
Postes actifs de Charles York
| Sociétés | Poste | Début |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/02/2021 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Directeur Financier/CFO | 17/02/2021 |
Anciens postes connus de Charles York
| Sociétés | Poste | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Directeur Financier/CFO | 12/02/2021 |
| ASTROTECH CO. | Comptroller/Controller/Auditor | 01/08/2012 |
Formation de Charles York
| University of Connecticut | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| ASTROTECH CO. | Electronic Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
